BANGKOK (The Nation/ANN): The National Vaccine Institute is in talks to purchase second-generation vaccines as booster shots against Covid-19 variants
Institute director Dr Nakorn Premsri said negotiations were underway with Novavax, whose second-gen protein subunit vaccine achieved 90 per cent efficacy against Covid infection in trials.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.